Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

soft tissue amyloid neoplasm - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

soft tissue amyloid neoplasm

MONDO:0024892

Also known as:amyloid neoplasmamyloid tumor (morphologic abnormality)amyloid tumour (morphologic abnormality)

Overview

A soft tissue neoplasm composed of acellular amyloid material.

TreatmentsNo approved treatments · 1 in pipeline

Diagnosis

Biomarker and diagnostic research for soft tissue amyloid neoplasm has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for soft tissue amyloid neoplasm. An additional 1 compound holds orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for soft tissue amyloid neoplasm, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for soft tissue amyloid neoplasm. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Brand Name	Generic Name	Sponsor

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for soft tissue amyloid neoplasm.

111 publications have been identified in PubMed for soft tissue amyloid neoplasm. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (32%), and Case Report / Case Series (12%).

Research Type	Count	% of Total
Laboratory research	41	37%

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:52 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What is the current development status of ifosfamide, and when might it become available?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

soft tissue amyloid neoplasm

Overview

Diagnosis

Treatment

Orphan Drug Designations

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Synovially-based soft tissue lesions of the knee: What is the rate of malignancy?

soft tissue amyloid neoplasm

Overview

Diagnosis

Treatment

Orphan Drug Designations

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Synovially-based soft tissue lesions of the knee: What is the rate of malignancy?